Page 9 - Newspaper_1
P. 9
9
Trump’s News CORONAVIRUS
US Trial Finds Drug
Cuts Coronavirus
Mortality 40%
By David A. Patten | newsmax
Perhaps the study's most and has a marked safety
impressive finding: The base,” he told Newsmax.
effect the drug had on 75 “We understand fully its side
sick COVID-19 patients who effects, and the effect of a
were suffering from “severe single dose in such a
pulmonary disease” – a very critically diseased state
high-risk group. cannot be ignored.”
Of patients in that group Hibberd tells Newsmax
Preliminary findings 25%. who did not receive that several major U.S.
released Tuesday for a U.S.- ivermectin, 81% died. Yet medical centers already list
based clinical trial of anti- That would equate to a the mortality rate for patients ivermectin as a COVID-19
parasite drug ivermectin 40% drop in mortality, a with severe pulmonary treatment. It is also
found that the mortality rate statistically significant disease who did receive reportedly being used to
for coronavirus patients fell difference. ivermectin was 39 percent. fight the virus in Bolivia,
40%, according to the Peru, India, and other
Medrxiv.org site. “It's amazing and could In other words, for the most nations.
literally pull people back severely ill patients with
The ivermectin study -- it from critical COVID-19 severe pulmonary disease, Over a dozen clinical trials
began in March as part of a illness,” according to board the use of ivermectin of the drug are also
larger Australian-led clinical c e r t i f i e d e m e r g e n c y improved the odds of reportedly underway in
study -- focused on 280 medicine physician Dr. survival by just over 50%. Egypt, Iraq, Argentina,
patients, 173 of whom were Peter Hibberd, M.D. Brazil, Mexico and Australia.
treated with the drug at four As news of ivermectin -- Ivermectin first emerged
Broward County, Florida, In an interview Tuesday, which is used globally to as a possible coronavirus
hospitals. Hibberd hailed the results as treat scabies, lice and other therapeutic when a study by
a “major breakthrough in parasitic diseases -- has researchers from Royal
The research team was led COVID-19 management.” spread on the internet, the Melbourne University and
by Dr. Jean-Jacques Rajter, FDA has warned patients Monash University in
a Broward Health Medical If reviewed successfully, against trying to treat Victoria, Australia showed
Center physician, and his Ivermectin could become themselves with it. the drug wiped out the virus
wife, Juliana Cepelowicz the first COVID-19 therapy in a test tube.
Rajter. shown to reduce mortality The FDA on May 1 posted
risk in seriously ill patients in the following advisory: Noting patients who
The findings reported in a clinical trial. “While there are approved received the drug in the
Medrxiv, “ICON (Ivermectin uses for ivermectin in people Broward County study were
in COVID-19) Study: Use of A previous therapeutic and animals, it is not already quite ill, Hibberd
Ivermectin Is Associated medication, remdesivir, has approved for the prevention suggested that giving
With Lower Mortality in a l r e a d y w o n F D A or treatment of COVID-19.” ivermectin to patients earlier
Hospitalized Patients With e m e r g e n c y u s e Ivermectin is generally in the disease cycle could be
COVID-19,” said that authorization. Trials showed considered safe, however, even more beneficial, and
patients who took part in the remdesivir shortened the FDA warned consumers might even help them avoid
trial were given a single patients' hospital stays, but to never use any form of the hospitalization altogether.
dose of the anti-parasitic did not show a statistically drug intended for use by
medication, and some significant improvement in animals. “That's why the results
received a second dose a reducing overall mortality, were so surprising,” he told
week later. according to the National Hibberd said that once the Newsmax, “because these
Institutes of Health. study is peer-reviewed, he people already had damage
The dose given the would like to see the FDA in their lungs with a rapidly
COVID-19 patients was the “Even if it was judged to grant emergency-use downhill progression.”
same as the FDA-approved need a second dose in authorization for ivermectin
dose used to treat patients seven days,” Hibberd said, as a coronavirus treatment – “Some of these patients
with intestinal parasites. “it remains a breakthrough in to be used under expert were in extreme distress
COVID-19 management.” medical supervision -- as and rapidly going downhill,”
According to Medrxiv.org, soon as possible. he added, “and their clinical
the Broward study found Medical experts aren't course stabilized with 24 to
that overall mortality among sure yet precisely how the When used as prescribed, 48 hours.”
seriously ill COVID-19 drug counters COVID-19. he said, ivermectin has a
patients treated with the Some suspect it could be very strong safety record. Some patients went home
drug was 15%. Mortality blocking a protein that the three to four days after
among patients in a similar virus requires in order to “This drug has been used receiving treatment, he said.
disease state who did not reproduce. for over 30 years by millions
receive ivermectin was of people around the world,
